Call Me - +39 3381508675 - E-Mail: info@cyberpharmaexcellence.com

  • CONTACTS
  • SUBSCRIBE TO MAILING LIST

CYBERPHARMA EXCELLENCE

 

"The exchange of information between Pharma companies in the industry"

 

  • HOME
  • NEWS - EVENTS
    • EVENTS
    • COURSES & CONGRESSES
    • PARTNERS NEWS
    • REGULATORY NEWS
    • PHARMACOVIGILANCE
    • MINISTRY OF HEALTH
    • CYBERPHARMA EXCELLENCE NEWS
  • CM
    • DRUGS
    • COSMETICS
    • DIETARY
    • MEDICAL DEVICE
    • DATA BANKS
  • MARKET PLACE
    • OFFERS
    • REQUESTS
    • PARTNERSHIP
  • PARTNERS
    • INDEX
      • 1. PHARMACEUTICAL
        • 1.1 Raw materials
        • 1.2 Pharmaceutical Products
        • 1.3 Homeopathic Products
        • 1.4 Medical Devices
        • 1.5 Cosmetic Products
        • 1.6 Dietetic and Herbal Products
        • 1.7 Contract manufacturing production - DRUGS
        • 1.8 Contract manufacturing Production - Supplements - Cosmetics - Med. devices
        • 1.9 Machinery and Equipment
      • 2. CONTROLS, ANALYSIS AND RESEARCH
      • 3. LOGISTICS
      • 4. PACKAGING
      • 5. ORGANIZATION AND TECHNICAL CONSULTANCY
      • 6. REGULATORY AFFAIRS
      • 7. MARKETING
      • 8. HUMAN RESOURCES
      • 8.1 TECHNICAL MAGAZINES
      • 9. GENERAL SERVICES
      • 10. TRAINING COURSES
  • BECOME PARTNER
    • PARTICIPATION IN EVENTS
    • ADV-WEB
    • THE CYBERPHARMAEXCELLENCE ® PARTNER
    • NETWORK PARTNERS
      • Cybermed Europe
      • Cybermed News
      • Cybermed Junior
      • Cybermed Life
    • WORK WITH US
  • CONVENTIONS
    • BOOKS & MAGAZINES
    • HOTELS & CONFERENCE CENTERS
    • PATENTS
    • TRANSLATIONS
    • INSURANCES
    • FUNDING
    • WEBSITES & ICT SERVICES
How to resolve AdBlock issue?
Refresh this page
Filters
List of articles in category CYBERPHARMA EXCELLENCE NEWS
Title Author Hits
Resistenza antimicrobica, oltre 20 aziende biofarmaceutiche investono 1 miliardo di dollari per la ricerca Written by Cyberpharmaexcellence Hits: 1547
Nuova strategia farmaceutica Ue, in arrivo una rivoluzione Written by Cyberpharmaexcellence Hits: 1680
Spesa farmaceutica Ssn 2019, calo dello 0,2% rispetto a 2018 Written by Cyberpharmaexcellence Hits: 1512
Farmaci a base di Montelukast, Aifa: rischio insorgenza effetti indesiderati di tipo neuropsichiatrico Written by Cyberpharmaexcellence Hits: 1535
Farmindustria, Scaccabarozzi confermato alla guida: usiamo il Mes per investire in ricerca Written by Cyberpharmaexcellence Hits: 1542
Indagine sieroprevalenza, farmacie impegnate come principale presidio sanitario Written by Cyberpharmaexcellence Hits: 1573
Farmaci per epilessia, vademecum Lice per vacanze sicure Written by Cyberpharmaexcellence Hits: 1614
Covid-19, Ue autorizza Remdesivir per trattamento in tempo record Written by Cyberpharmaexcellence Hits: 1591
Coronavirus, documento Coalizione delle autorità regolatorie farmaci: No a studi su pochi pazienti Written by Cyberpharmaexcellence Hits: 1627
Oppioidi, arriva il no dall’Aifa per l’utilizzo in caso di dolore lieve Written by Cyberpharmaexcellence Hits: 1414

Page 8 of 16

  • Start
  • Prev
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next
  • End
How to resolve AdBlock issue?
Refresh this page

 

CYBERPHARMA EXCELLENCE

bY - M.A.B. Art Decò

Piazzale A. La Marmora, 13
01030 Monterosi (VT) ITALY
P.IVA: 08724920585

N° ROC REGISTER: 21797

 

 

Facebook

Follow us on facebook

qr-code

Cookie

Cookie Policy

Privacy

Privacy Policy

Visitorcounter

All 724311

Currently are 16 guests and no members online

GDPR Data Collection

GDPR

Copyright Cyberpharma Excellence © 2020. All Rights Reserved.

Back to top

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.

Ok
More information